Analyst Coverage

"The challenge lies with the regulatory pathway and what product claims you want to make." said Brent Barnes, CEO of LBT Innovations

The working APAS Independence will be showcased at a major clinical microbiology conference next month, and launched by end of 2017.

Share price surged by 358% percent this week, following announcement of the receipt of clearance from the FDA for The Automatic Plate Assessment System (APAS).